Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Rep Med. 2025 Jan 18:101944. doi: 10.1016/j.xcrm.2025.101944. Online ahead of print.
No abstract available

Publication types

  • Published Erratum